Urecsys
Patent-protected solutions in the battle against urban air pollution have been proven consistently efective, with unprecedented success in improving indoor air quality across urban environments.
- B2B
- saas
- manufacturing
- health
- real estate
- biotechnology
- machine learning
- iot internetofthings
- hardware
- artificial intelligence
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
$3.0m | Late VC | ||
| Total Funding | 000k | ||
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 111 % |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Urecsys is an environmental health technology company focused on improving indoor air quality and reducing urban air pollution. The company serves a diverse range of clients including commercial buildings, educational institutions, and residential properties. Operating in the environmental technology market, Urecsys employs a business model centered around the deployment of its advanced air quality systems. These systems use artificial intelligence to regulate air circulation, ensuring only the cleanest air enters buildings. Revenue is generated through the sale and maintenance of these systems, as well as through data analytics services that provide insights into air quality patterns. Urecsys leverages a team of innovative thought leaders, including published research scientists and experienced entrepreneurs, to pioneer solutions that protect both health and the environment.
Keywords: indoor air quality, urban air pollution, environmental technology, artificial intelligence, air circulation, commercial buildings, educational institutions, residential properties, data analytics, greenhouse gas reduction.